Medco Reaches Risk-Sharing Rebate Agreements For 75% Of Part D Spend
This article was originally published in The Pink Sheet Daily
Executive Summary
The PBM is "very comfortable" that its rebating model is not outside of legal safe harbors, CEO Snow says. Under such formulary agreements, Medco receives incremental rebates when utilization exceeds set levels within a therapeutic category.